| 1. |
- Pujari-Palmer, Michael, et al.
(författare)
-
A Novel Class of Injectable Bioceramics That Glue Tissues and Biomaterials
- 2018
-
Ingår i: Materials. - : MDPI AG. - 1996-1944. ; 11:12
-
Tidskriftsartikel (refereegranskat)abstract
- Calcium phosphate cements (CPCs) are clinically effective void fillers that are capable of bridging calcified tissue defects and facilitating regeneration. However, CPCs are completely synthetic/inorganic, unlike the calcium phosphate that is found in calcified tissues, and they lack an architectural organization, controlled assembly mechanisms, and have moderate biomechanical strength, which limits their clinical effectiveness. Herein, we describe a new class of bioinspired CPCs that can glue tissues together and bond tissues to metallic and polymeric biomaterials. Surprisingly, alpha tricalcium phosphate cements that are modified with simple phosphorylated amino acid monomers of phosphoserine (PM-CPCs) bond tissues up to 40-fold stronger (2.5-4 MPa) than commercial cyanoacrylates (0.1 MPa), and 100-fold stronger than surgical fibrin glue (0.04 MPa), when cured in wet-field conditions. In addition to adhesion, phosphoserine creates other novel properties in bioceramics, including a nanoscale organic/inorganic composite microstructure, and templating of nanoscale amorphous calcium phosphate nucleation. PM-CPCs are made of the biocompatible precursors calcium, phosphate, and amino acid, and these represent the first amorphous nano-ceramic composites that are stable in liquids.
|
|
| 2. |
- Forsgren, Johan, et al.
(författare)
-
Co-loading of bisphosphonates and antibiotics to a biomimetic hydroxyapatite coating.
- 2011
-
Ingår i: Biotechnology letters. - : Springer Science and Business Media LLC. - 1573-6776 .- 0141-5492. ; 33:6, s. 1265-8
-
Tidskriftsartikel (refereegranskat)abstract
- We have incorporated bisphosphonates and antibiotics simultaneously into a biomimetic hydroxyapatite implant coating aiming to use the interaction between drug-molecules and hydroxyapatite to enable local release of the two different substances to obtain a dual biological effect. A sustained release over for 43 h of antibiotics (cephalothin) was achieved without negative interference from the presence of the bisphosphonate (clodronate) which, in turn, successfully bonded to the coating surface. To our knowledge, this is the first study that indicates the possibility to simultaneously incorporate both antibiotics and bisphosphonates to an implant coating, a strategy that is believed to improve implant stability and reduce implant-related infections.
|
|
| 3. |
- Lindahl, Carl, et al.
(författare)
-
Biomimetic calcium phosphate coating of additively manufactured porous CoCr implants
- 2015
-
Ingår i: Applied Surface Science. - : Elsevier BV. - 0169-4332 .- 1873-5584. ; 353, s. 40-47
-
Tidskriftsartikel (refereegranskat)abstract
- The aim of this work was to study the feasibility to use a biomimetic method to prepare biomimetic hydroxyapatite (HA) coatings on CoCr substrates with short soaking times and to characterize the properties of such coatings. A second objective was to investigate if the coatings could be applied to porous CoCr implants manufactured by electron beam melting (EBM). The coating was prepared by immersing the pretreated CoCr substrates and EBM implants into the phosphate-buffered solution with Ca2+ in sealed plastic bottles, kept at 60 degrees C for 3 days. The formed coating was partially crystalline, slightly calcium deficient and composed of plate-like crystallites forming roundish flowers in the size range of 300-500 nm. Cross-section imaging showed a thickness of 300-500 nm. In addition, dissolution tests in Tris-HCl up to 28 days showed that a substantial amount of the coating had dissolved, however, undergoing only minor morphological changes. A uniform coating was formed within the porous network of the additive manufactured implants having similar thickness and morphology as for the flat samples. In conclusion, the present coating procedure allows coatings to be formed on CoCr and could be used for complex shaped, porous implants made by additive manufacturing.
|
|
| 4. |
- Mathew, Renny, et al.
(författare)
-
Solid-State NMR Rationalizes the Bone-Adhesive Properties of Serine- and Phosphoserine-Bearing Calcium Phosphate Cements by Unveiling Their Organic/Inorganic Interface
- 2020
-
Ingår i: The Journal of Physical Chemistry C. - : American Chemical Society (ACS). - 1932-7447 .- 1932-7455. ; 124:39, s. 21512-21531
-
Tidskriftsartikel (refereegranskat)abstract
- From a multitude of homonuclear and heteronuclear correlation magic-angle-spinning (MAS) NMR experiments, we present thorough structural and phase-quantification analyses of calcium phosphate cements (CPCs) that incorporate either L-serine (Ser) or O-phospho-L-serine (Pser), thereby rendering the cements strongly bone-adhesive and suitable for biomedical implants with capacity to glue both soft and hard tissues together. In the absence of organic additives, the CPCs comprise disordered hydroxyapatite (HA), which forms from the reaction of alpha-Ca-3(PO4)(2) with water. However, the presence of even a few mol % of Pser/Ser drastically changes the cement reactions: the HA formation is quenched, while MAS NMR experiments reveal intimate contacts between the Pser/Ser molecules and amorphous calcium phosphate (ACP) that incorporate HPO42- groups: these organic/inorganic species form a homogeneous amorphous ACP/Pser or ACP/Ser cement component. The amount of ACP/Pser in the cement is shown to correlate qualitatively with its shear strength, also rationalizing why Pser-bearing CPCs exhibit stronger adhesive properties than their Ser-based counterparts, for which the ACP/Ser content does not increase concomitantly with that of Ser (as for the Pser-based CPCs). The Pser-bearing CPCs feature the strongest shear strength for 23-72 mol % Pser, whereas the decline of the adhesive properties for the Pser-richest CPCs (>72 mol %) stems from unreacted Pser and formation of its Ca salt, as well as several minor Ca phosphate phases involving HPO42- and H2PO4- groups. By combining information from various one- and two-dimensional MAS NMR experiments with H-1, C-13, and P-31 as structural probes, we examined the inorganic/organic contacts of the ACP/Pser and ACP/Ser phases, and monitored the alterations of the cement reactions for variable amounts of the organic additives.
|
|
| 5. |
|
|
| 6. |
- Procter, Philip, et al.
(författare)
-
Designing A Commercial Biomaterial For A Specific Unmet Clinical Need – : An Adhesive Odyssey
- 2018
-
Konferensbidrag (refereegranskat)abstract
- There are clinical situations in fracture repair, e.g. osteochondral fragments, where current implant hardware is insufficient. The proposition of an adhesive enabling fixation and healing has been considered but no successful candidate has emerged thus far. The many preclinical and few clinical attempts include fibrin glue, mussel adhesive and even “Kryptonite” (US bone void filler). The most promising recent attempts are based on phosphorylating amino acids, part of a common cellular adhesion mechanism linking mussels, caddis fly larvae, and mammals. Rapid high bond strength development in the wetted fatty environment of fractured bone, that is sustained during biological healing, is challenging to prove both safety and efficacy. Additionally, there are no “predicate” preclinical animal and human models which led the authors to develop novel evaluations for an adhesive candidate “OsStictm” based on calcium salts and amino acids. Adhesive formulations were evaluated in both soft (6/12 weeks) and hard tissue (3,7,10,14 & 42 days) safety studies in murine models. The feasibility of a novel adhesiveness test, initially proven in murine cadaver femoral bone, is being assessed in-vivo (3,7,10,14 & 42 days) in bilateral implantations with a standard tissue glue as the control. In parallel an ex-vivo human bone model using freshly harvested human donor bone is under development to underwrite the eventual clinical application of such an adhesive. This is part of a risk mitigation project bridging between laboratory biomaterial characterisation and a commercial biomaterial development where safety and effectiveness have to meet today´s new medical device requirements.
|
|
| 7. |
- Skjöldebrand, Charlotte, et al.
(författare)
-
Si-Fe-C-N Coatings for Biomedical Applications : A Combinatorial Approach
- 2020
-
Ingår i: Materials. - : MDPI. - 1996-1944 .- 1996-1944. ; 13:9
-
Tidskriftsartikel (refereegranskat)abstract
- Ceramic coatings may prolong the lifetime of joint implants. Certain ions and wear debris may however lead to negative biological effects. SiN-based materials may substantially reduce these effects, but still need optimization for the application. In this study, a combinatorial deposition method enabled an efficient evaluation of a range of Si-Fe-C-N coating compositions on the same sample. The results revealed compositional gradients of Si (26.0-33.9 at.%), Fe (9.6-20.9 at.%), C (8.2-13.9 at.%) and N (39.7-47.2 at.%), and low oxygen contaminations (0.3-0.6 at.%). The mechanical properties varied with a hardness (H) ranging between 13.7-17.3 GPa and an indentation modulus (M) between 190-212 GPa. Both H and M correlated with the Si (H and M increased as Si increased) and Fe (H and M decreased as Fe increased) content. A slightly columnar morphology was observed in cross-sections, as well as a surface roughness in the nm range. A cell study revealed adhering pre-osteogenic MC3T3 cells, with a morphology similar to that of cells seeded on a tissue culture plastic control. The investigated coatings could be considered for further investigation due to the ability to tune their mechanical properties while maintaining a smooth surface, together with their promising in vitro cell response.
|
|
| 8. |
- Katsaros, Ioannis, et al.
(författare)
-
Bioactive Silicon Nitride Implant Surfaces with Maintained Antibacterial Properties
- 2022
-
Ingår i: Journal of Functional Biomaterials. - : MDPI. - 2079-4983 .- 2079-4983. ; 13:3
-
Tidskriftsartikel (refereegranskat)abstract
- Silicon nitride (Si3N4) is a promising biomaterial, currently used in spinal fusion implants. Such implants should result in high vertebral union rates without major complications. However, pseudarthrosis remains an important complication that could lead to a need for implant replacement. Making silicon nitride implants more bioactive could lead to higher fusion rates, and reduce the incidence of pseudarthrosis. In this study, it was hypothesized that creating a highly negatively charged Si3N4 surface would enhance its bioactivity without affecting the antibacterial nature of the material. To this end, samples were thermally, chemically, and thermochemically treated. Apatite formation was examined for a 21-day immersion period as an in-vitro estimate of bioactivity. Staphylococcus aureus bacteria were inoculated on the surface of the samples, and their viability was investigated. It was found that the thermochemically and chemically treated samples exhibited enhanced bioactivity, as demonstrated by the increased spontaneous formation of apatite on their surface. All modified samples showed a reduction in the bacterial population; however, no statistically significant differences were noticed between groups. This study successfully demonstrated a simple method to improve the in vitro bioactivity of Si3N4 implants while maintaining the bacteriostatic properties.
|
|
| 9. |
- Cai, Bing, et al.
(författare)
-
Bioceramic microneedles with flexible and self-swelling substrate
- 2015
-
Ingår i: European journal of pharmaceutics and biopharmaceutics. - : Elsevier BV. - 0939-6411 .- 1873-3441. ; 94, s. 404-410
-
Tidskriftsartikel (refereegranskat)abstract
- To reduce the effort required to penetrate the skin and optimize drug release profiles, bioceramic microneedle arrays with higher-aspect-ratio needles and a flexible and self-swelling substrate have been developed. Swelling of the substrate can assist in separating it from the needles and leave them in the skin as a drug depot. The preparation procedures for this bioceramic microneedle are described in the paper. Clonidine hydrochloride, the model drug, was released in a controlled manner by the microneedle device in vitro. Results showed that the microneedle array with a flexible and self-swelling substrate released the drug content faster than the array with a rigid substrate. Disintegration of the needle material and diffusion of the drug molecules are believed as the main control mechanisms of the drug release from these microneedle arrays. Ex vivo skin penetration showed that they can effectively penetrate the stratum corneum without an extra device. This work represents a progression in the improvement of bioceramic microneedles for transdermal drug delivery.
|
|
| 10. |
|
|
